A Randomized Phase II Selection Trial of Venetoclax-Based Induction Intensity in Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT07754799 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07754799
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2029-09-30
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.